Simple reversed-phase high-performance liquid chromatography quantitation of ganciclovir in human serum and urine

被引:38
作者
Page, T
Sherwood, C
Connor, JD
Tarnowski, T
机构
[1] UNIV CALIF SAN DIEGO,DEPT PEDIAT,LA JOLLA,CA 92093
[2] ROCHE BIOSCI,PALO ALTO,CA 94303
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1996年 / 675卷 / 02期
关键词
ganciclovir;
D O I
10.1016/0378-4347(95)00381-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A fast, simple, and cost-effective HPLC method for the quantitation of the antiviral drug ganciclovir is described. The serum samples are extracted with perchloric acid and neutralized with potassium phosphate buffer, and urine samples are diluted with distilled water. A reversed-phase column with isocratic elution by 15 mM potassium phosphate buffer (pH 2.5) containing 0.25% acetonitrile is used to separate ganciclovir; quantitation is by UV absorbance at 254 nm. Total turnaround time is 22 min; more than 3000 samples can be run on a single column without loss of peak quality. The limit of quantitation is 0.05 mu g/ml. Recoveries varied from 91 to 107% with coefficients of variation ranging from 0.387 to 7.95%.
引用
收藏
页码:342 / 346
页数:5
相关论文
共 8 条
[1]   INVITRO AND INVIVO ACTIVITIES OF PHOSPHATE DERIVATIVES OF 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)-GUANINE AGAINST CYTOMEGALOVIRUSES [J].
DUKE, AE ;
SMEE, DF ;
CHERNOW, M ;
BOEHME, R ;
MATTHEWS, TR .
ANTIVIRAL RESEARCH, 1986, 6 (05) :299-308
[2]   HUMAN PHARMACOKINETICS OF THE ANTIVIRAL DRUG DHPG [J].
FLETCHER, C ;
SAWCHUK, R ;
CHINNOCK, B ;
DEMIRANDA, P ;
BALFOUR, HH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (03) :281-286
[3]   HUMAN PHARMACOKINETICS AND TOLERANCE OF ORAL GANCICLOVIR [J].
JACOBSON, MA ;
DEMIRANDA, P ;
CEDERBERG, DM ;
BURNETTE, T ;
COBB, E ;
BRODIE, HR ;
MILLS, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (08) :1251-1254
[4]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[5]   GANCICLOVIR - AN UPDATE OF ITS THERAPEUTIC USE IN CYTOMEGALOVIRUS-INFECTION [J].
MARKHAM, A ;
FAULDS, D .
DRUGS, 1994, 48 (03) :455-484
[6]   COMPARATIVE INHIBITORY EFFECTS OF NUCLEOSIDE ANALOGS ON DIFFERENT CLINICAL ISOLATES OF HUMAN CYTOMEGALOVIRUS INVITRO [J].
SHIGETA, S ;
KONNO, K ;
BABA, M ;
YOKOTA, T ;
DECLERCQ, E .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :270-275
[7]   ANTIVIRAL ACTIVITY OF ANTICYTOMEGALOVIRUS AGENTS (HPMPC, HPMPA) ASSESSED BY A FLOW CYTOMETRIC METHOD AND DNA HYBRIDIZATION TECHNIQUE [J].
SNOECK, R ;
SCHOLS, D ;
ANDREI, G ;
NEYTS, J ;
DECLERCQ, E .
ANTIVIRAL RESEARCH, 1991, 16 (01) :1-9
[8]   LINEAR SINGLE-DOSE PHARMACOKINETICS OF GANCICLOVIR IN NEWBORNS WITH CONGENITAL CYTOMEGALOVIRUS INFECTIONS [J].
TRANG, JM ;
KIDD, L ;
GRUBER, W ;
STORCH, G ;
DEMMLER, G ;
JACOBS, R ;
DANKNER, W ;
STARR, S ;
PASS, R ;
STAGNO, S ;
ALFORD, C ;
SOONG, SJ ;
WHITLEY, RJ ;
SOMMADOSSI, JP .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (01) :15-21